Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Gastroduodenal effects of parecoxib assessed in the elderly

May 29, 2000

Ropinirole reduces the risk of dyskinesia in early Parkinson's disease

May 29, 2000

Favorable safety and efficacy data reported for Concerta; FDA issues approvable letter

May 29, 2000

Dopamine D3 receptor modulators claimed by SB for use in schizophrenia

May 26, 2000

Pfizer synthesizes new N/OFQ receptor agonists

May 26, 2000

Selective AMPA receptor antagonists and their use presented by Schering AG

May 26, 2000

New series of glutamate receptor antagonists in development at Warner-Lambert

May 26, 2000

Phase II trials of Perceptin under way at Gliatech

May 26, 2000

Gene linked to stress identified independently by two groups

May 26, 2000

Allergan to collaborate on developing neurotoxin-based analgesics

May 25, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...